| Stage | MAR | % of rev | SHO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.1B | 100.00% | $277M | 100.00% | MAR ×25.52 |
| Gross profit | $1.6B | 21.98% | $172M | 62.05% | SHO +40.1pp |
| Operating income | $1.2B | 17.38% | $34M | 12.34% | MAR +5.0pp |
| Pre-tax income | $1.0B | 14.76% | $26M | 9.46% | MAR +5.3pp |
| Net income | $766M | 10.83% | $26M | 9.39% | MAR +1.4pp |
| Stage | MAR | SHO | Gap · A − B |
|---|---|---|---|
| Revenue | $7.1B100.00% | $277M100.00% | MAR ×25.52 |
| Gross profit | 21.98%$1.6B | 62.05%$172M | SHO +40.1pp |
| Operating income | 17.38%$1.2B | 12.34%$34M | MAR +5.0pp |
| Pre-tax income | 14.76%$1.0B | 9.46%$26M | MAR +5.3pp |
| Net income |
| 10.83%$766M |
| 9.39%$26M |
| MAR +1.4pp |
No shared counterparties.